Company Filing History:
Years Active: 2019-2022
Title: Laurence J Neil Cooper: Innovator in Immunotherapy
Introduction
Laurence J Neil Cooper is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on genetically modified T cells. With a total of 2 patents, Cooper's research focuses on advancing treatment options for various medical conditions.
Latest Patents
Cooper's latest patents include groundbreaking methods and compositions for immunotherapy that utilize CAR+ T cells genetically modified to eliminate the expression of T-cell receptors and/or HLA. These inventions aim to create modified T cells that can be used allogeneically as universal reagents for 'off-the-shelf' treatment of medical conditions such as cancer, autoimmunity, and infection. In particular embodiments, the T cell receptor-negative and/or HLA-negative T cells are generated using zinc finger nucleases, showcasing the innovative techniques employed in his research.
Career Highlights
Cooper is affiliated with the University of Texas System, where he continues to push the boundaries of medical research. His work has garnered attention for its potential to revolutionize immunotherapy and improve patient outcomes.
Collaborations
Cooper collaborates with fellow researcher Hiroki Torikai, contributing to the advancement of their shared goals in the field of immunotherapy.
Conclusion
Laurence J Neil Cooper's innovative work in the field of immunotherapy exemplifies the potential of genetic modification in treating serious medical conditions. His contributions are paving the way for future advancements in medical science.